American Brain Tumor Association

American Brain Tumor Association. The American Brain Tumor Association (ABTA) is a non-profit organization dedicated to advancing the understanding and treatment of brain tumors, such as glioblastoma, medulloblastoma, and meningioma, through research and education, in collaboration with institutions like the National Institutes of Health (NIH) and the American Cancer Society. The ABTA was founded in 1973 by Susan Kramer, a brain tumor survivor, and has since become a leading organization in the field, working closely with hospitals like Massachusetts General Hospital and Memorial Sloan Kettering Cancer Center. The ABTA has supported research conducted by prominent scientists, including James Allison, Elizabeth Blackburn, and David Julius, who have made significant contributions to the field of cancer research.

● History

The American Brain Tumor Association was established in 1973 with the goal of improving the lives of brain tumor patients, such as those diagnosed with ependymoma or craniopharyngioma, and their families, through research, education, and support, in partnership with organizations like the Brain Tumor Foundation and the National Brain Tumor Society. The ABTA has a long history of collaboration with renowned institutions, including the University of California, San Francisco (UCSF), Duke University, and the University of Texas MD Anderson Cancer Center. Over the years, the ABTA has funded research grants to scientists at Harvard University, Stanford University, and the University of Chicago, leading to significant advances in the understanding and treatment of brain tumors, including the development of new therapies like temozolomide and bevacizumab. The ABTA has also worked closely with patient advocacy groups, such as the National Organization for Rare Disorders (NORD) and the Rare Diseases Clinical Research Network (RDCRN), to raise awareness about brain tumors and promote research into rare and aggressive brain tumors, like gliosarcoma and primitive neuroectodermal tumors (PNETs).

● Mission_and_Objectives

The mission of the American Brain Tumor Association is to advance the understanding and treatment of brain tumors through research, education, and support, in collaboration with organizations like the American Association for Cancer Research (AACR) and the Society for Neuro-Oncology (SNO). The ABTA's objectives include funding research into the causes and treatment of brain tumors, such as astrocytoma and oligodendroglioma, and providing support and education to patients and their families, in partnership with hospitals like Johns Hopkins Hospital and University of California, Los Angeles (UCLA). The ABTA also aims to raise awareness about brain tumors and promote collaboration among researchers, clinicians, and patients, through events like the Annual Meeting of the American Association for Cancer Research and the International Symposium on Brain Tumors. The ABTA has supported research into new therapies, including immunotherapy and targeted therapy, and has worked with scientists at institutions like the Fred Hutchinson Cancer Research Center and the Sloan-Kettering Institute to develop new treatments for brain tumors.

● Research_and_Programs

The American Brain Tumor Association funds research grants to scientists at institutions like the National Cancer Institute (NCI), Columbia University, and the University of Pennsylvania, to study the causes and treatment of brain tumors, including pineal region tumors and skull base tumors. The ABTA also supports research into new therapies, such as gene therapy and stem cell therapy, and has collaborated with organizations like the Brain Tumor Research Center at the University of California, San Francisco (UCSF) and the Neuro-Oncology Branch at the National Cancer Institute (NCI). The ABTA has also established programs to support patients and their families, including the ABTA Support Services and the ABTA Clinical Trials program, which provides information on clinical trials for brain tumor patients, in partnership with organizations like the Coalition of Cancer Cooperative Groups and the Society for Neuro-Oncology (SNO). The ABTA has worked with researchers at institutions like the Dana-Farber Cancer Institute and the H. Lee Moffitt Cancer Center & Research Institute to develop new treatments for brain tumors.

● Advocacy_and_Support

The American Brain Tumor Association provides support and education to patients and their families, in partnership with organizations like the National Patient Advocate Foundation (NPAF) and the Cancer Support Community. The ABTA offers a range of resources, including the ABTA Support Services and the ABTA Clinical Trials program, which provides information on clinical trials for brain tumor patients, in collaboration with institutions like the MD Anderson Cancer Center and the University of California, San Diego (UCSD). The ABTA also advocates for policies and legislation that support brain tumor research and patient care, working closely with organizations like the National Brain Tumor Society and the Brain Tumor Foundation. The ABTA has worked with patient advocacy groups, such as the Rare Diseases Legislative Advocates (RDLA) and the National Organization for Rare Disorders (NORD), to raise awareness about brain tumors and promote research into rare and aggressive brain tumors.

● Organization_and_Leadership

The American Brain Tumor Association is led by a board of directors composed of experts in the field of neuro-oncology, including doctors and researchers from institutions like the University of California, Los Angeles (UCLA) and the Duke University School of Medicine. The ABTA is headquartered in Chicago, Illinois, and has a staff of professionals who work to advance the organization's mission and objectives, in collaboration with organizations like the American Cancer Society and the National Institutes of Health (NIH). The ABTA has a strong network of volunteers and donors who support the organization's work, including philanthropists like Michael J. Fox and Norman Schwarzkopf Jr., who have contributed to the organization's research and education programs.

● Events_and_Fundraising

The American Brain Tumor Association hosts a range of events and fundraising campaigns to support its mission and objectives, including the ABTA Charity Golf Tournament and the ABTA Walk/Run for Brain Tumor Research. The ABTA also participates in national events, such as the National Brain Tumor Awareness Month and the World Cancer Day, to raise awareness about brain tumors and promote research into new treatments, in partnership with organizations like the American Association for Cancer Research (AACR) and the Society for Neuro-Oncology (SNO). The ABTA has received support from corporations like Pfizer and Merck & Co., and has collaborated with foundations like the Bill and Melinda Gates Foundation and the Michael J. Fox Foundation to advance research into brain tumors and develop new therapies. The ABTA has also worked with institutions like the University of Oxford and the Karolinska Institutet to promote international collaboration and advance research into brain tumors.